23andMe, Inc., a Mountain View, CA-based personal genetics company, has raised more than $50m in a Series D financing.
Backers include Yuri Milner, a new investor, as well as existing investors Sergey Brin, 23andMe CEO Anne Wojcicki, New Enterprise Associates, Google Ventures and MPM Capital.
The company, which currently has more than 180,000 customers, intends to use the funding to “help the company achieve its growth goal of one million customers” as well as to increase its research and operational capabilities, including product development, genetic research, software development, recruitment (https://www.23andme.com/about/jobs/) and marketing.
Founded in 2006 and led by CEO Anne Wojcicki, 23andMe provides a Personal Genome Service, which enables individuals to understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company just reduced the price of the service to $99.